剪接体突变的临床试验
总计1649个结果
-
Thai Red Cross AIDS Research CentreChulalongkorn University; Queen Savang Vadhana Memorial Hospital, Thailand完全的
-
Boehringer Ingelheim主动,不招人
-
University of California, San FranciscoThe Bluefield Project to Cure Frontotemporal Dementia完全的
-
AZ-VUB未知
-
Weill Medical College of Cornell University完全的
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Istituto Oncologico di Bari完全的
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘难治性淋巴瘤 | DLBCL | MYD88基因突变 | 复发 | CD79A基因突变 | CD79B基因突变
-
University of California, Los AngelesBoston Children's Hospital; Duke University; Children's Hospital Medical Center, Cincinnati招聘中
-
Universitaire Ziekenhuizen KU Leuven完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC主动,不招人
-
University of Chicago招聘中
-
Affiliated Hospital to Academy of Military Medical...招聘中
-
The University of Hong Kong未知
-
Okayama UniversityMerck Sharp & Dohme LLC招聘中乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | BRCA1突变 | BRCA2突变 | BRCA突变 | BRCA 相关性乳腺癌日本
-
Korean Cancer Study Group未知
-
Shandong UniversityFudan University; Chinese Nutrition Society暂停
-
Boehringer Ingelheim主动,不招人
-
Massachusetts General HospitalAgios Pharmaceuticals, Inc.完全的
-
xCuresCancer Commons可用的黑色素瘤 | 头颈癌 | 胶质母细胞瘤 | 肝细胞癌 | 胃癌 | 大肠癌 | 胰腺癌 | 食道癌 | 小肠癌 | 卵巢癌 | 非小细胞肺癌 | 胆管癌 | 膀胱癌 | 甲状腺癌 | ERK突变 | MAPK基因突变 | KRAS 激活突变 | BRAF基因突变 | NRAS基因突变 | HRAS基因突变 | MEK突变美国
-
NYU Langone Health撤销乳腺癌 | BRCA1突变 | BRCA2突变美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人BRCA1基因突变 | BRCA2基因突变 | 转移性恶性肿瘤 | 晚期恶性肿瘤 | 复发性恶性肿瘤 | 难治性恶性肿瘤 | PALB2基因突变 | ATM基因突变美国
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.招聘中非小细胞肺癌 | BRAF V600突变 | MET扩增 | MET 外显子 14 跳跃突变 | RET驱动突变 | Erb-B2 受体酪氨酸激酶外显子 20 突变中国
-
Georgetown UniversityImmune System Key Ltd招聘中
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre; Takeda Canada,... 和其他合作者招聘中癌症 | 多发性恶性肿瘤 | 恶性实体瘤 | 癌症,治疗相关 | 分子序列变异 | 遗传改变 | 基因融合 | 受体酪氨酸激酶基因突变 | RTK家族基因突变 | Ras(Kras 或 Nras)基因突变加拿大
-
Royal Marsden NHS Foundation Trust完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.尚未招聘BRCA1突变 | BRCA2突变 | PALB2基因突变 | 激素受体阳性 HER-2 阴性乳腺癌 | 晚期或转移性乳腺癌德国
-
Intergroupe Francophone de Cancerologie Thoracique完全的
-
Hellenic Cooperative Oncology Group主动,不招人
-
Shirley Ryan AbilityLabUniversity of Alberta招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)未知乳腺癌 | brca1突变携带者 | brca2突变携带者美国
-
Centre Hospitalier Universitaire de Besancon完全的
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Worcester...完全的
-
Istituto Clinico HumanitasCelgene未知
-
Calithera Biosciences, Inc完全的
-
Hunan Province Tumor Hospital招聘中